Study | Red cell transfusion within the first 6 h | Vasopressor infusion within the first 6 h | Dobutamine use within the first 6 h | Mechanical ventilation within the first 6 h | APACHE II score | |||||
---|---|---|---|---|---|---|---|---|---|---|
EGDT | UC/LGT | EGDT | UC/LGT | EGDT | UC/LGT | EGDT | UC/LGT | EGDT | UC/LGT | |
Rivers 2001 [4] | 83 (63.8%) | 27 (20.3%) | 36 (27.7%) | 40 (30.1%) | 18 (13.8%) | 1 (0.8%) | 69 (53.1%) | 72 (54.1%) | 21.4 ± 6.9 | 20.4 ± 7.4 |
Lin 2006 [31] | 39 (36.1%) | 43 (37.1%) | 80 (74.1%) | 81 (69.8%) | 13 (12.0%) | 16 (13.8%) | – | – | – | – |
Wang 2006 [32] | – | – | – | – | – | – | 4 (25.0%) | 5 (29.4%) | 28.0 ± 7.0 | 27.0 ± 6.0 |
Chen 2007 [29] | – | – | – | – | – | – | – | – | 16.53 ± 6.87 | 16.68 ± 7.14 |
He 2007 [30] | – | – | – | – | – | – | – | – | – | – |
Yan 2010 [27] | – | – | – | – | – | – | – | – | 23.5 ± 5.7 | 21.8 ± 6.5 |
Andrews 2014 [28] | 16 (30.2%) | 11 (19.7%) | – | – | 1 (1.9%) | 3 (5.4%) | – | – | – | – |
ARISE 2014 [7] | 108 (13.6%) | 56 (7.1%) | 528 (66.7%) | 461 (57.9%) | 122 (15.4%) | 21 (2.7%) | 276 (34.8%) | 263 (33.0%) | 15.4 ± 6.5 | 15.8 ± 6.5 |
ProCESS 2014 [6] | 63 (14.4%) | 37 (8.1%) | 241 (54.9%) | 201 (44.1%) | 35 (8.0%) | 5 (1.1%) | 165 (37.6%) | 146 (32.0%) | 20.8 ± 8.1 | 20.7 ± 7.5 |
ProMISe 2015 [8] | 55 (8.8%) | 24 (3.9%) | 332 (53.3%) | 291 (46.9%) | 113 (18.1%) | 24 (3.9%) | 179 (28.7%) | 175 (28.2%) | 18.7 ± 7.1 | 18 ± 7.1 |
Jansen 2010 [14] | – | – | 113 (63.8%) | 119 (69.6%) | 58 (32.8%) | 69 (40.4%) | – | – | 22.7 ± 9.1 | 23.6 ± 8.6 |
Jones 2010 [15] | 5 (3.3%) | 11 (7.3%) | 113 (75.3%) | 108 (73.5%) | 8 (5.3%) | 5 (3.3%) | 39 (26.0%) | 40 (26.7%) | – | – |
Tian 2012 [17] | – | – | – | – | – | – | – | – | 20.9 ± 8.6 | 17.8 ± 6.3 |
Yu 2013 [13] | 5 (20.0%) | 4 (16.0%) | 20 (80.0%) | 18 (72.0%) | 1 (4%) | 2 (8%) | 19 (76%) | 20 (80%) | 17.91 ± 3.77 | 18.18 ± 6.01 |
Wang 2014 [18] | – | – | – | – | – | – | – | – | 19.7 ± 3.1 | 20.9 ± 7.6 |
Lv 2015 [16] | – | – | – | – | – | – | – | – | – | – |